- alphabeta T - Helper Cell Dependency in the Development of Anticardiolipin and Anti - beta2 Glycoprotein I Antibodies in MRL / MP - lpr / lpr Mice
-
Kang IS
- KMID: 2082994
- Korean J Immunol.
- 1997 Sep;19(3):301-306.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Antiphospholipid Syndrome Presented With Anterior Spinal Artery Syndrome
-
Kim J, Kim YD, Na SJ
- KMID: 1966524
- J Korean Neurol Assoc.
- 2012 Aug;30(3):200-202.
Antibodies to cardiolipin and other phospholipid have been associated with recurrent thrombotic events, including ischemic strokes, especially in children and young adults. Recently it has been shown that anti-beta2-glycoprotein I... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Systemic Lupus Erythematosus and Abdominal Aorta Thrombosis Associated with Protein C and S Deficiency
-
Song JH, Gweon TG, Min JK
- KMID: 2334882
- J Korean Rheum Assoc.
- 2009 Dec;16(4):306-311.
Thrombosis is a well known manifestation in patients with systemic lupus erythematosus, along with lupus anticoagulant, anticardiolipin antibody and anti beta2-glycoprotein I. We describe here a 44-year-old female with an... -
- CITED
-
- Close
- SHARE
-
- Close
- A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach
-
Karkhah A, Amani J
- KMID: 2152697
- Clin Exp Vaccine Res.
- 2016 Jan;5(1):50-59.
- doi: 10.7774/cevr.2016.5.1.50
PURPOSE: Atherosclerosis is classically defined as an immune-mediated disease characterized by accumulation of low-density lipoprotein cholesterol over intima in medium sized and large arteries. Recent studies have demonstrated that both... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Anti-beta2-Glycoprotein I Antibody Test for the Diagnosis of Antiphospholipid Syndrome
-
Lee HR, Kim TY, Kim SE
- KMID: 2089511
- Korean J Clin Pathol.
- 1998 Jun;18(2):240-244.
BACKGROUND: The conventional anticardiolipin antibody (aCL)-ELISA test that has been widely used to diagnose antiphospholipid syndrome (APS) has drawbacks in that false-positive reactions can occur. There have been considerable controversy... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiphospholipid and Antinuclear Antibodies in Children with Idiopathic Epilepsy: A 2-Year Prospective Study
-
Attilakos , Fotis L, Dinopoulos A, Alexopoulos H, Theofilopoulou AV, Tzioufas A, Mastroyianni S, Karalexi M, Garoufi A
- KMID: 2467796
- J Clin Neurol.
- 2020 Jan;16(1):140-144.
- doi: 10.3988/jcn.2020.16.1.140
BACKGROUND AND PURPOSE: The high prevalence of antiphospholipid antibodies (aPL) and antinuclear antibodies (ANA) in patients with epilepsy may be associated with either the disease itself or the antiepileptic treatment.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Antiphospholipid Syndrome Presenting as Pulmonary Infarction and Multiple Arterial Thromboembolism
-
Koo SE, Jang JY, Lim YJ, Lee SY, Kim HB, Hong SJ
- KMID: 2314393
- Pediatr Allergy Respir Dis.
- 2005 Sep;15(3):316-323.
Antiphospholipid syndrome (APS) is a noninflammatory autoimmune disorder characterized by the association of arterial and/or venous thrombosis, recurrent fetal loss and elevated titres of antiphospholipid antibodies, namely lupus anticoagulant (LAC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
-
Pyo JY, Jung SM, Lee SW, Song JJ, Lee SK, Park YB
- KMID: 2418894
- Yonsei Med J.
- 2017 Nov;58(6):1128-1134.
- doi: 10.3349/ymj.2017.58.6.1128
PURPOSE: International consensus criteria for antiphospholipid syndrome (APS) require persistently positive antiphospholipid antibodies (aPL) and medium or high titers in association with clinical manifestations. However, the clinical relevance of persistence... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Silica Clotting Time for Detection of Lupus Anticoagulants
-
Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI
- KMID: 1781601
- Korean J Lab Med.
- 2009 Dec;29(6):497-504.
- doi: 10.3343/kjlm.2009.29.6.497
BACKGROUND: The presence of lupus anticoagulants (LA) is a strong risk factor for thrombosis in antiphospholipid syndrome. We investigated the usefulness of addition of silica clotting time (SCT) to the... -
- CITED
-
- Close
- SHARE
-
- Close
